Effective April 21:
Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) is now Schedule III (changed from Schedule II).
Fall 2024 ACP Connect: introducing the new standards
October 1, 2024
Nearly 500 registrants joined ACP in person and online.
Read more ➞